Navigation Links
Abbott to Feature Novel Tests and New Upgrades to Testing Platforms at American Association for Clinical Chemistry Lab Expo
Date:7/26/2010

ANAHEIM, Calif., July 26 /PRNewswire-FirstCall/ -- A first-of-its-kind test that detects HIV infection earlier than ever before in the United States; a molecular assay for identification of two common sexually transmitted diseases; and an enhanced integrated analyzer offering significant workflow improvements; are among the many new advances Abbott (NYSE: ABT) will highlight at this year's American Association for Clinical Chemistry Lab Expo (AACC) which starts today in Anaheim. In all, Abbott is sponsoring 29 scientific posters reporting on new clinical diagnostics research in areas such as heart disease or cardiac care, transplant, renal disease and cancer; three scientific industry workshops; and 15 main stage presentations at the Abbott exhibit booth (#6808).

"Abbott is focused on improving patient care by offering innovative solutions for our laboratory customers and the patients and physicians they serve," said Brian Blaser, senior vice president, Diagnostics, Abbott. "At this year's AACC, we will feature our latest assays and systems which offer solutions to meet the demanding needs of healthcare institutions by improving operational efficiency, clinical outcomes, and physician, patient, and laboratory satisfaction."

Abbott AACC Highlights

  • Advances in HIV Testing Foster Early Detection: Last month, the FDA approved Abbott's ARCHITECT HIV Antigen/Antibody Combo Assay, a first-of-its-kind new HIV diagnostic tool. Since the test detects both HIV antigens and antibodies, Abbott's test can identify infection days earlier than other an
    '/>"/>

SOURCE Abbott
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Abbott Receives Supplemental FDA Approval for its Best-in-Class in Sensitivity RealTime HIV-1 Viral Load Test
2. Abbott and AstraZeneca Announce Selection of Next-Generation Fenofibrate ABT-335 and CRESTOR(R) Fixed-Dose Combination
3. Abbott Initiates Clinical Study to Evaluate Use of RX Herculink(R) Elite(TM) Renal Stent System for the Treatment of Renal Artery Stenosis
4. Abbotts ABT-874 Shows Positive Results for Maintenance of Response in Phase II Psoriasis Study
5. Abbotts XIENCE(TM) V Everolimus Eluting Coronary Stent Shows Continued Superiority to TAXUS Stent in Reducing Major Adverse Cardiac Events in SPIRIT III Clinical Trial
6. Abbott Announces Positive One-Year Results from the Worlds First Clinical Trial of a Fully Bioabsorbable Drug Eluting Coronary Stent
7. Abbotts m2000(TM) Molecular Diagnostic Instrument and RealTime HIV-1 Test Win Chicago Innovation Award
8. Abbotts HUMIRA(R) (adalimumab) Receives FDA Approval For Moderate to Severe Chronic Plaque Psoriasis
9. Abbotts XIENCE(TM) V Drug Eluting Stent Demonstrates Consistent and Positive Clinical Outcomes Out to Two Years
10. Abbotts Phase III Studies of Investigational TriLipix(TM) (ABT-335), in Combination With Statins, Meets Primary Endpoints on Improving LDL, Triglycerides and HDL
11. Study in JAMA Shows Patients Treated With Abbotts XIENCE(TM) V Drug Eluting Stent Experience Better Outcomes Than Patients Treated With Market-Leading Drug Eluting Stent
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/23/2014)... YORK , September 23, 2014 ... pioneer in computer-aided dysmorphology analysis will exhibit at the ... Diego, CA. FDNA will present the latest ... and reference solution, using facial analysis technology. Face2Gene facilitates ... of human malformations from facial photos. The ...
(Date:9/23/2014)... , Sept. 23, 2014  Medela announced today ... Biomedical Company (ABC), assigning Medela as the exclusive distributor ... known as the Medela Enteral Feeding Pump. Through this ... help NICU parents and healthcare professionals by offering a ... Medela Enteral Feeding Pump is integral to the delivery ...
(Date:9/23/2014)... N.J. , Sept. 23, 2014  Soligenix, ... late-stage biopharmaceutical company developing products that address unmet ... and biodefense, announced today that it has appointed ... President of Biopharmaceutical Development.  Dr. Arumugham has over ... and development (R&D) in the areas of formulation ...
Breaking Medicine Technology:FDNA to Exhibit at ASHG2014 Presenting Face2Gene Integrated With London Medical Databases (LMD) Online 2Medela Enters Exclusive Enteral Feeding Pump Agreement with Atlanta Biomedical Company 2Soligenix Appoints Rasappa Arumugham, PhD, as Vice President of Biopharmaceutical Development 2Soligenix Appoints Rasappa Arumugham, PhD, as Vice President of Biopharmaceutical Development 3Soligenix Appoints Rasappa Arumugham, PhD, as Vice President of Biopharmaceutical Development 4
... HbA1c reductions seen in ischemic patients with ... diabetes in earlier clinical trials -, ... ) announced today that data from a prospectively identified,analysis of ... (ranolazine extended-release tablets) significantly reduced,hemoglobin A1c (HbA1c), increased the number ...
... Cleveland Clinic Researchers Highlight the Need For More Women to ... ... Cleveland Clinic,researchers have recently found that women remain a significant ... and Blood Institute (NHLBI). Lead Author, Esther S.H. Kim, ...
Cached Medicine Technology:CV Therapeutics' Anti-Ischemic Agent Ranexa(R) Significantly Reduces HbA1c and Other Markers of Diabetes in MERLIN TIMI-36 2CV Therapeutics' Anti-Ischemic Agent Ranexa(R) Significantly Reduces HbA1c and Other Markers of Diabetes in MERLIN TIMI-36 3CV Therapeutics' Anti-Ischemic Agent Ranexa(R) Significantly Reduces HbA1c and Other Markers of Diabetes in MERLIN TIMI-36 4Enrollment of Women in Cardiovascular Trials Fails to Meet Current Federal Mandates 2
(Date:9/23/2014)... September 23, 2014 With summer at ... in spirit and weather), organic food manufacturing company Earth ... month centered on sweet treats for the whole family. ... bite-sized candies by the handful in celebration of the ... recent years these festivities come with an increasing degree ...
(Date:9/23/2014)... IL (PRWEB) September 23, 2014 ... solutions, has expanded its MedMaster™ M4 product line ... luminaire extends the M4 product line – currently ... LED options – providing more flexibility when designing ... the MedMaster M4 Series include:, •Three ...
(Date:9/23/2014)... On September 20- 21, 2014, people ... two days of Trivedi Retreat ‘Consciousness is Power’, online ... the Energy Transmissions from Mahendra Trivedi and Trivedi Masters™ ... people enjoyed the In-person, group and live Energy Transmissions ... Trivedi and Trivedi Master™ Alice Branton, where, they described ...
(Date:9/23/2014)... (HealthDay News) -- Pregnant women appear to have an ... a new study. And this strong immune ... from the flu than other healthy adults. The reason: ... immune system responding to the virus, the researchers said. ... that pregnancy weakens the immune system to keep it ...
(Date:9/23/2014)... On September 8th, the company XenOPAT SL, a spin-off ... Catalan Institute of Oncology (ICO) was established with the ... to the service combating cancer with two main branches: ... of personalized cancer treatments. , Orthotopic models and ... the use of orthotopic models (orthoxenograft) mouse by implantation ...
Breaking Medicine News(10 mins):Health News:Righteously Raw Chocolates Promote Healthy, Fun Snacking this Fall Season 2Health News:Kenall Expands MedMaster™ M4 Surgical Suite Product Portfolio with New 1'×4' Option 2Health News:Kenall Expands MedMaster™ M4 Surgical Suite Product Portfolio with New 1'×4' Option 3Health News:The Trivedi Retreat ‘Consciousness is Power’ was Huge Success 2Health News:The Trivedi Retreat ‘Consciousness is Power’ was Huge Success 3Health News:Study Suggests Why Pregnant Women Get Sicker From Flu 2Health News:Study Suggests Why Pregnant Women Get Sicker From Flu 3Health News:XenOPAT, mouse models for personalized cancer treatment 2
... ... ... ... ...
... ... ... ... ...
... ... ... , ... TULSA, Okla. , Feb. 19 U.S. ...
... more fumes that are likely carcinogenic than with electric ranges ... hot stove -- make that a hot gas ... cancer. , Researchers in Norway have found that cooking with ... , But, in a report published online Feb. 17 in ...
... (P4P) programs are payment models that reward workers for ... the healthcare setting, P4P programs use a variety of ... fee differentials and bonuses. A new study ... that P4P programs appear to be effective in incentivizing ...
... ... momentum created by local communities and the NGO Tostan to end the practice by 2015 ... Dakar, Senegal (PRWEB) February ... cutting (FGC) which has seen thousands of communities in Senegal join its ranks in recent ...
Cached Medicine News:Health News:New Gallup Poll Quantifies U.S. Physician Opinions on the Scope of Defensive Medicine Practices 2Health News:New Gallup Poll Quantifies U.S. Physician Opinions on the Scope of Defensive Medicine Practices 3Health News:New Gallup Poll Quantifies U.S. Physician Opinions on the Scope of Defensive Medicine Practices 4Health News:Abbott Announces 10 Percent Increase in Quarterly Dividend 2Health News:Abbott Announces 10 Percent Increase in Quarterly Dividend 3Health News:Two Tulsa Pharmacies Penalized for Missing Prescription Drugs 2Health News:Two Tulsa Pharmacies Penalized for Missing Prescription Drugs 3Health News:Gas Cooking Might Up Your Cancer Risk 2Health News:Gas Cooking Might Up Your Cancer Risk 3Health News:Senegal: Total End of Female Genital Cutting Now in Sight 2
... The 1700 Series Outpatient Surgical Table ... standards as Skytron's other specialty and general ... their key features such as 180-degree top ... extremely durable side rails will accommodate a ...
23" Top Slide with Full Table Functions for Every Procedure...
... operating table for any application. The ... unlimited C-arm access. High stability guarantees ... and cardiovascular procedures. An extension device ... can easily be attached for orthopedic ...
As with all Eschmann products the T20 operating table was designed with 'Simplicity and Intuitiveness' in mind, having drawn influences from leading clinicians of various levels from across the globe...
Medicine Products: